Literature DB >> 21720382

Impact of TP53 mutation and 17p deletion in mantle cell lymphoma.

A M Halldórsdóttir, A Lundin, F Murray, L Mansouri, S Knuutila, C Sundström, A Laurell, H Ehrencrona, B Sander, R Rosenquist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21720382     DOI： 10.1038/leu.2011.162

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  28 in total

1.  Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP53 alterations.

Authors:  Richard J Lin; Caleb Ho; Patrick D Hilden; Juliet N Barker; Sergio A Giralt; Paul A Hamlin; Ann A Jakubowski; Hugo R Castro-Malaspina; Kevin S Robinson; Esperanza B Papadopoulos; Miguel-Angel Perales; Craig S Sauter
Journal:  Br J Haematol       Date:  2018-12-11       Impact factor: 6.998

2.  Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing.

Authors:  Prasath Pararajalingam; Krysta M Coyle; Sarah E Arthur; Nicole Thomas; Miguel Alcaide; Barbara Meissner; Merrill Boyle; Quratulain Qureshi; Bruno M Grande; Christopher Rushton; Graham W Slack; Andrew J Mungall; Constantine S Tam; Rishu Agarwal; Sarah-Jane Dawson; Georg Lenz; Sriram Balasubramanian; Randy D Gascoyne; Christian Steidl; Joseph Connors; Diego Villa; Timothy E Audas; Marco A Marra; Nathalie A Johnson; David W Scott; Ryan D Morin
Journal:  Blood       Date:  2020-07-30       Impact factor: 22.113

3.  Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma.

Authors:  Christian Winther Eskelund; Alexandra Albertsson-Lindblad; Arne Kolstad; Anna Laurell; Riikka Räty; Lone Bredo Pedersen; Christian Hartmann Geisler; Mats Jerkeman; Kirsten Grønbæk
Journal:  Haematologica       Date:  2018-05-24       Impact factor: 9.941

Review 4.  Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.

Authors:  Arantza Onaindia; L Jeffrey Medeiros; Keyur P Patel
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

Review 5.  Mantle cell lymphoma--a spectrum from indolent to aggressive disease.

Authors:  Birgitta Sander; Leticia Quintanilla-Martinez; German Ott; Luc Xerri; Isinsu Kuzu; John K C Chan; Steven H Swerdlow; Elias Campo
Journal:  Virchows Arch       Date:  2015-08-23       Impact factor: 4.064

Review 6.  Toward a Risk-Tailored Therapeutic Policy in Mantle Cell Lymphoma.

Authors:  Adalgisa Condoluci; Davide Rossi; Emanuele Zucca; Franco Cavalli
Journal:  Curr Oncol Rep       Date:  2018-08-22       Impact factor: 5.075

7.  Clinical and functional impact of recurrent S1PR1 mutations in mantle cell lymphoma.

Authors:  Agata M Wasik; Chenglin Wu; Larry Mansouri; Richard Rosenquist; Qiang Pan-Hammarström; Birgitta Sander
Journal:  Blood Adv       Date:  2018-03-27

Review 8.  Management of Mantle Cell Lymphoma in the Era of Novel Oral Agents.

Authors:  Michael J Buege; Anita Kumar; Brianne N Dixon; Laura A Tang; Terry Pak; Jennifer Orozco; Tim J Peterson; Kathryn T Maples
Journal:  Ann Pharmacother       Date:  2020-02-20       Impact factor: 3.154

Review 9.  Optimizing therapy for mantle cell lymphoma.

Authors:  Peter Martin
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

10.  Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL.

Authors:  Preetesh Jain; Shaojun Zhang; Rashmi Kanagal-Shamanna; Chi Young Ok; Krystle Nomie; Graciela Nogueras Gonzalez; Omarya Gonzalez-Pagan; Holly A Hill; Hun Ju Lee; Luis Fayad; Jason Westin; Loretta Nastoupil; Frederick Hagemeister; Wendy Chen; Onyeka Oriabure; Maria Badillo; Changying Jiang; Yao Yixin; Shaoying Li; Guilin Tang; C Cameron Yin; Keyur P Patel; Leonard Jeffrey Medeiros; Ranjit Nair; Sairah Ahmed; Swaminathan P Iyer; Selvi Thirumurthi; Richard Champlin; Guofan Xu; Pan Tinsu; David Santos; Ruiping Wang; Guangchun Han; Jianhua Zhang; Xingzhi Song; Sattva Neelapu; Jorge Romaguera; Andy Futreal; Christopher Flowers; Nathan Fowler; Linghua Wang; Michael L Wang
Journal:  Blood Adv       Date:  2020-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.